Chun-Ze Zhou
Overview
Explore the profile of Chun-Ze Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang L, Zhu Y, Wang X, Wang R, Dong L, Yin L, et al.
Hepatol Int
. 2024 Apr;
18(4):1227-1237.
PMID: 38594475
Background And Aims: Performing a Transjugular intrahepatic portal system shunt (TIPS) in patients with portal vein cavernous transformation (CTPV) poses significant challenges. As an alternative, transjugular extrahepatic portal vein shunt...
2.
Sun F, Liu K, Ain Q, Lu D, Zhou C, Xiao J, et al.
BMC Gastroenterol
. 2024 Apr;
24(1):129.
PMID: 38589828
Background: The HAP, Six-and-Twelve, Up to Seven, and ALBI scores have been substantiated as reliable prognostic markers in patients presenting with intermediate and advanced hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization...
3.
Yin L, Chu S, Lv W, Zhou C, Liu K, Zhu Y, et al.
World J Gastroenterol
. 2023 Jun;
29(18):2875-2887.
PMID: 37274064
Background: Skeletal muscle abnormalities, such as muscle mass depletion (sarcopenia) and fatty infiltration of the muscle (myosteatosis), are frequent complications in cirrhotic patients scheduled for transjugular intrahepatic portosystemic shunt (TIPS)....
4.
Yin L, Liu K, Lv W, Xu S, Lu D, Zhou C, et al.
Drug Des Devel Ther
. 2022 Oct;
16:3421-3429.
PMID: 36203820
Objective: To validate the robust predictive values of tumor vascularity and reactive cutaneous capillary endothelial proliferation (RCCEP) in combination treatment of transarterial chemoembolization (TACE) and camrelizumab for patients with advanced...
5.
Li J, Chen X, Zhou C, Fang W, Lv W, Cheng D
World J Gastrointest Surg
. 2021 Dec;
13(11):1448-1462.
PMID: 34950433
Background: Budd-Chiari syndrome (BCS) is an uncommon disorder characterized by obstruction of hepatic venous outflow. To date, the exact mechanism underlying hepatic injury derived from the hepatic venous outflow obstruction...
6.
Wang R, Zhou C, Fu Y, Lv W
J Int Med Res
. 2021 Jan;
49(1):300060520985733.
PMID: 33478297
Nutcracker syndrome (NCS) refers to characteristic clinical symptoms that develop secondary to the nutcracker phenomenon (NCP), defined as compression of the left renal vein between the superior mesenteric artery and...
7.
Liu K, Hao Y, Lv W, Jia W, Ji C, Zhou C, et al.
Drug Des Devel Ther
. 2020 Sep;
14:3461-3468.
PMID: 32904650
Purpose: Transcatheter arterial chemoembolization (TACE) and targeted therapy have become common methods in the treatment of advanced hepatocellular carcinoma (HCC). The purpose of this study was to evaluate the safety...
8.
Zhou C, Wang R, Lv W, Fu Y, Cheng D, Zhu Y, et al.
World J Gastroenterol
. 2020 Jul;
26(24):3472-3483.
PMID: 32655270
Background: Treatments for hepatic sinusoidal obstruction syndrome (HSOS) are limited. Aim: To evaluate transjugular intrahepatic portosystemic shunting (TIPS) as a treatment for pyrrolidine alkaloid-related HSOS (PA-HSOS). Methods: This retrospective analysis...
9.
Zhou C, Liu K, Wang P, Ren W, Lv W
Exp Ther Med
. 2019 Oct;
18(4):2979-2983.
PMID: 31572540
Central venous catheter is one of the most commonly used vascular therapies in patients receiving hemodialysis and vascular perforation is a rare but serious complication. The present study reports on...
10.
Zhou C, Wang R, Cheng D, Zhu Y, Cao Q, Lv W
Biomed Pharmacother
. 2019 Sep;
118:109031.
PMID: 31545219
Background: This study was conducted to investigate the protective effect of Fms-like tyrosine kinase 3 (FLT3)/FLT3 ligand (FLT3L)-dependent CD103 dendritic cells (DCs) on hepatic ischemia-reperfusion injury (IRI). Methods: A mouse...